Meyka Pro banner
Penumbra, Inc.

Penumbra, Inc. Fundamental Analysis (NYSE: PEN)

PENNYSE
HealthcareMedical - Devices
$326.75
$0.17(0.05%)
U.S. Market opens in 3h 8m

Penumbra, Inc. Fundamental Analysis (NYSE: PEN)

Penumbra, Inc. (NYSE: PEN) shows weak financial fundamentals with a PE ratio of 79.90, profit margin of 10.67%, and ROE of 11.09%. The company generates $1.5B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Current Ratio5.75

Areas of Concern

PEG Ratio11.77
We analyze PEN's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 69.9/100 based on profitability, valuation, growth, and balance sheet metrics. The C+ grade reflects average fundamentals, with notable risks in certain areas.

Fundamental Health Score

C+
69.9/100

We analyze PEN's fundamental strength across five key dimensions:

Efficiency Score

Weak

PEN struggles to generate sufficient returns from assets.

ROA > 10%
8.13%

Valuation Score

Weak

PEN trades at a premium to fair value.

PE < 25
79.90
PEG Ratio < 2
11.77

Growth Score

Moderate

PEN shows steady but slowing expansion.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

PEN maintains a strong and stable balance sheet.

Debt/Equity < 1
0.14
Current Ratio > 1
5.75

Profitability Score

Weak

PEN struggles to sustain strong margins.

ROE > 15%
11.09%
Net Margin ≥ 15%
10.67%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is PEN Expensive or Cheap?

P/E Ratio

PEN trades at 79.90 times earnings. This suggests a premium valuation.

79.90

PEG Ratio

When adjusting for growth, PEN's PEG of 11.77 indicates potential overvaluation.

11.77

Price to Book

The market values Penumbra, Inc. at 8.39 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

8.39

EV/EBITDA

Enterprise value stands at 57.88 times EBITDA. This signals the market has high growth expectations.

57.88

How Well Does PEN Make Money?

Net Profit Margin

For every $100 in sales, Penumbra, Inc. keeps $10.67 as profit after all expenses.

10.67%

Operating Margin

Core operations generate 12.45 in profit for every $100 in revenue, before interest and taxes.

12.45%

ROE

Management delivers $11.09 in profit for every $100 of shareholder equity.

11.09%

ROA

Penumbra, Inc. generates $8.13 in profit for every $100 in assets, demonstrating efficient asset deployment.

8.13%

Following the Money - Real Cash Generation

Operating Cash Flow

Penumbra, Inc. produces operating cash flow of $278.33M, showing steady but balanced cash generation.

$278.33M

Free Cash Flow

Penumbra, Inc. generates strong free cash flow of $216.32M, providing ample flexibility for dividends, buybacks, or growth.

$216.32M

FCF Per Share

Each share generates $5.49 in free cash annually.

$5.49

FCF Yield

PEN converts 1.68% of its market value into free cash.

1.68%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

79.90

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

11.77

vs 25 benchmark

P/B Ratio

Price to book value ratio

8.39

vs 25 benchmark

P/S Ratio

Price to sales ratio

8.55

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.14

vs 25 benchmark

Current Ratio

Current assets to current liabilities

5.75

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.11

vs 25 benchmark

ROA

Return on assets percentage

0.08

vs 25 benchmark

ROCE

Return on capital employed

0.11

vs 25 benchmark

How PEN Stacks Against Its Sector Peers

MetricPEN ValueSector AveragePerformance
P/E Ratio79.9031.50 Worse (Expensive)
ROE11.09%422.00% Weak
Net Margin10.67%19867.00% Weak
Debt/Equity0.140.53 Strong (Low Leverage)
Current Ratio5.755.56 Strong Liquidity
ROA8.13%1571.00% Weak

PEN outperforms its industry in 2 out of 6 key metrics, but lagging in P/E Ratio.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Penumbra, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ